制酸剤の世界市場（2023年～2027年）：規模・予測・業界動向・成長・インフレの影響・機会・企業分析

世界の制酸剤の市場規模は、2022年～2027年の間に3.78%のCAGRで拡大し、2027年に105億米ドルに達する見込みです。

制酸剤市場の開拓は、主に業務の組み直しやCOVID-19の影響から回復を図る企業に起因しています。COVID-19は、リモートワーク、ソーシャルディスタンス、商業活動の閉鎖を含む制限的な封じ込め策につながり、業務上の課題を生じさせました。

デスクワーク、睡眠の質の低下、不規則な食生活などのライフスタイルの悪化は、胃の酸性度を高め、胃食道逆流症につながるため、制酸剤市場の成長に不可欠な要因となっています。

当レポートでは、世界の制酸剤市場を調査し、市場概要、促進要因や課題、市場シェア、薬剤クラス・剤形・流通チャネル・地域別市場、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因
• 課題

第5章 世界の制酸剤市場

第6章 世界の制酸剤市場：市場シェア

• 薬剤クラス別
• 剤形別
• 流通チャネル別
• 地域別

第7章 世界の制酸剤市場：薬剤クラス別

• プロトンポンプ阻害剤
• H2拮抗薬
• 酸中和剤

第8章 世界の制酸剤市場：剤形別

• 錠剤
• 液体
• 粉末

第9章 世界の制酸剤市場：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第10章 世界の制酸剤市場：地域別

• 北米
• 欧州
• アジア太平洋地域
• 南米
• 中東・アフリカ

第11章 企業分析

• Pfizer Inc
• GlaxoSmithKline plc.
• Dr. Reddy's Laboratories Ltd
• Johnson & Johnson
• Bayer AG
• Sanofi
• Abbott Laboratories

List of Figures

• Figure-01: Global - Antacids Market (Billion US$), 2017 - 2022
• Figure-02: Global - Forecast for Antacids Market (Billion US$), 2023 - 2027
• Figure-03: Drug Class - Proton Pump Inhibitor Market (Million US$), 2017 - 2022
• Figure-04: Drug Class - Forecast for Proton Pump Inhibitor Market (Million US$), 2023 - 2027
• Figure-05: Drug Class - H2 Antagonist Market (Million US$), 2017 - 2022
• Figure-06: Drug Class - Forecast for H2 Antagonist Market (Million US$), 2023 - 2027
• Figure-07: Drug Class - Acid Neutralizers Market (Million US$), 2017 - 2022
• Figure-08: Drug Class - Forecast for Acid Neutralizers Market (Million US$), 2023 - 2027
• Figure-09: Dosage Form - Tablet Market (Million US$), 2017 - 2022
• Figure-10: Dosage Form - Forecast for Tablet Market (Million US$), 2023 - 2027
• Figure-11: Dosage Form - Liquid Market (Million US$), 2017 - 2022
• Figure-12: Dosage Form - Forecast for Liquid Market (Million US$), 2023 - 2027
• Figure-13: Dosage Form - Powder Market (Million US$), 2017 - 2022
• Figure-14: Dosage Form - Forecast for Powder Market (Million US$), 2023 - 2027
• Figure-15: Distribution Channel - Hospital Pharmacies Market (Million US$), 2017 - 2022
• Figure-16: Distribution Channel - Forecast for Hospital Pharmacies Market (Million US$), 2023 - 2027
• Figure-17: Distribution Channel - Retail Pharmacies Market (Million US$), 2017 - 2022
• Figure-18: Distribution Channel - Forecast for Retail Pharmacies Market (Million US$), 2023 - 2027
• Figure-19: Distribution Channel - Online Pharmacies Market (Million US$), 2017 - 2022
• Figure-20: Distribution Channel - Forecast for Online Pharmacies Market (Million US$), 2023 - 2027
• Figure-21: North America - Antacids Market (Million US$), 2017 - 2022
• Figure-22: North America - Forecast for Antacids Market (Million US$), 2023 - 2027
• Figure-23: Europe - Antacids Market (Million US$), 2017 - 2022
• Figure-24: Europe - Forecast for Antacids Market (Million US$), 2023 - 2027
• Figure-25: Asia Pacific - Antacids Market (Million US$), 2017 - 2022
• Figure-26: Asia Pacific - Forecast for Antacids Market (Million US$), 2023 - 2027
• Figure-27: South America - Antacids Market (Million US$), 2017 - 2022
• Figure-28: South America - Forecast for Antacids Market (Million US$), 2023 - 2027
• Figure-29: Middle East & Africa - Antacids Market (Million US$), 2017 - 2022
• Figure-30: Middle East & Africa - Forecast for Antacids Market (Million US$), 2023 - 2027
• Figure-31: Pfizer Inc - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-32: Pfizer Inc - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
• Figure-33: GlaxoSmithKline plc. - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-34: GlaxoSmithKline plc. - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
• Figure-35: Dr. Reddy's Laboratories Ltd - Global Revenue Market (Million US$), 2017 - 2022
• Figure-36: Dr. Reddy's Laboratories Ltd - Forecast for Global Revenue Market (Million US$), 2023 - 2027
• Figure-37: Johnson & Johnson - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-38: Johnson & Johnson - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
• Figure-39: Bayer AG - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-40: Bayer AG - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
• Figure-41: Sanofi - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-42: Sanofi - Forecast for Global Revenue Market (Billion US$), 2023 - 2027
• Figure-43: Abbott Laboratories - Global Revenue Market (Billion US$), 2017 - 2022
• Figure-44: Abbott Laboratories - Forecast for Global Revenue Market (Billion US$), 2023 - 2027

List of Tables

• Table-01: Global - Antacids Market Share by Drug Class (Percent), 2017 - 2022
• Table-02: Global - Forecast for Antacids Market Share by Drug Class (Percent), 2023 - 2027
• Table-03: Global - Antacids Market Share by Dosage Form (Percent), 2017 - 2022
• Table-04: Global - Forecast for Antacids Market Share by Dosage Form (Percent), 2023 - 2027
• Table-05: Global - Antacids Market Share by Distribution Channel (Percent), 2017 - 2022
• Table-06: Global - Forecast for Antacids Market Share by Distribution Channel (Percent), 2023 - 2027
• Table-07: Global - Antacids Market Share by Regions (Percent), 2017 - 2022
• Table-08: Global - Forecast for Antacids Market Share by Regions (Percent), 2023 - 2027

Global Antacids Market will reach US$ 10.50 Billion in 2027 according to Renub Research. Globally, antacids are widely used for treating ulcers, inflammation, dyspepsia discomfort, sore stomach, stomach acid indigestion, and stomach upset. It is an over-the-counter (OTC) medication that neutralizes the acid in the stomach to relieve indigestion and heartburn. Further, they contain ingredients like magnesium hydroxide, sodium bicarbonate, calcium, and aluminum are commonly available in convenient chewable powder, tablets, and liquid forms. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.

Antacids Market Size is likely to expand at a CAGR of 3.78 % during 2022 - 2027:

The development in the antacids market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had prior led to restrictive containment measures involving remote working, social distancing, and the closure of commercial activities that resulted in operational challenges.

Poor lifestyle adoptions such as deskbound jobs, poor sleep quality, and irregular dietary habits, which increases the acidity level of the stomach and lead to gastroesophageal reflux disease, are essential drivers for the evolution of the antacids market. As per the American College of Gastroenterology, about 60 million Americans suffer from gastroesophageal reflux disease.

Tablets are Expected to Hold a Major Market Share:

By Dosage Form, Tablet was estimated to be the largest segment. Chewable tablets in different flavors help improve patient adherence to the medication, which in turn is expected to contribute to the segment's growth. In addition, tablets are easy to store and can provide the exact dosage amount to the patients compared to the other dosage forms. According to our research findings Antacids Market Size is likely to expand at a CAGR of 3.78% during 2022 - 2027.

Distribution Channel Insights:

By distribution channel, the market is trifurcated into retail pharmacies, online pharmacies, and hospital pharmacies. Online pharmacy is the fastest-growing segment over the forecast period due to increasing consumer awareness. In addition, people are picking online pharmacies due to lucrative offers, such as price discounts, ease in the availability of drugs, and home delivery services. Furthermore, the increasing adoption of information technology in the healthcare sector aids clinicians in sending prescriptions electronically, which is expected to boost growth.

Based on Region, North America is the most significant market for Antacids:

The North American antacids market is anticipated to grow significantly due to lifestyle changes and the rising geriatric population leading to gastrointestinal problems among the American people. Also, the trend towards self-medication in countries such as the United States is increasing the demand for OTC (over-the-counter) digestive products, such as antacids. As a result, antacids are the most common over-the-counter products in the United States.

Impact of COVID-19 on Antacids market:

Market growth was hampered by declining production, a lockdown, and a labor shortage during the COVID-19 epidemic. As a result, the prices were higher than usual. But due to the rising demand for new antacids, the market will be growing in the coming years. Furthermore, the COVID-19 pandemic caused a transient spike in antacid sales, which led to panic buying among individuals who had severe medical conditions like gastroesophageal reflux disease and obesity. Additionally, it was witnessed that various gastrointestinal medications successfully enhanced the clinical results of hospitalized COVID-19 patients.

Key Players:

Pfizer Inc, GlaxoSmithKline plc., Dr. Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, and Abbott Laboratories, are the leading competitors in the Antacids industry. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.

Renub Research latest report "Antacids Market, Forecast By Drug Class (Proton Pump Inhibitor, H2 Antagonist, Acid Neutralizers), Dosage Form (Tablet, Liquid, Powder), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region ( North America, Europe, Asia Pacific,South America, Middle East & Africa), Companies (Pfizer Inc, GlaxoSmithKline plc., Dr Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, Abbott Laboratories)" provides a detailed analysis of Global Antacids Market.

Drug Class - The market has been studied from 3 viewpoints:

• 1. Proton Pump Inhibitor
• 2. H2 Antagonist
• 3. Acid Neutralizers

Dosage Form - The market has been studied from 3 viewpoints:

• 1. Tablet
• 2. Liquid
• 3. Powder

Distribution Channel - The market has been studied from 3 viewpoints:

• 1. Hospital Pharmacies
• 2. Retail Pharmacies
• 3. Online Pharmacies

By Region - The market has been studied from 5 viewpoints:

• 1. North America
• 2. Europe
• 3. Asia Pacific
• 4. South America
• 5. Middle East & Africa

Company Insights:

• Overview
• Initiatives/Recent Developments
• Financial Insight

Companies Covered:

• 1. Pfizer Inc
• 2. GlaxoSmithKline plc.
• 3. Dr Reddy's Laboratories Ltd
• 4. Johnson & Johnson
• 5. Bayer AG
• 6. Sanofi
• 7. Abbott Laboratories

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

• 4.1 Growth Drivers
• 4.2 Challenges

5. Global Antacids Market

6. Market Share - Global Antacids Market

• 6.1 By Drug Class
• 6.2 By Dosage Form
• 6.3 By Distribution Channel
• 6.4 By Region

7. Drug Class - Global Antacids Market

• 7.1 Proton Pump Inhibitor
• 7.2 H2 Antagonist
• 7.3 Acid Neutralizers

8. Dosage Form - Global Antacids Market

• 8.1 Tablet
• 8.2 Liquid
• 8.3 Powder

9. Distribution Channel - Global Antacids Market

• 9.1 Hospital Pharmacies
• 9.2 Retail Pharmacies
• 9.3 Online Pharmacies

10. Region - Global Antacids Market

• 10.1 North America
• 10.2 Europe
• 10.3 Asia Pacific
• 10.4 South America
• 10.5 Middle East & Africa

11. Company Analysis

• 11.1 Pfizer Inc
  • 11.1.1 Overview
  • 11.1.2 Recent Development
  • 11.1.3 Financial Insights
• 11.2 GlaxoSmithKline plc.
  • 11.2.1 Overview
  • 11.2.2 Recent Development
  • 11.2.3 Financial Insights
• 11.3 Dr. Reddy's Laboratories Ltd
  • 11.3.1 Overview
  • 11.3.2 Recent Development
  • 11.3.3 Financial Insights
• 11.4 Johnson & Johnson
  • 11.4.1 Overview
  • 11.4.2 Recent Development
  • 11.4.3 Financial Insights
• 11.5 Bayer AG
  • 11.5.1 Overview
  • 11.5.2 Recent Development
  • 11.5.3 Financial Insights
• 11.6 Sanofi
  • 11.6.1 Overview
  • 11.6.2 Recent Development
  • 11.6.3 Financial Insights
• 11.7 Abbott Laboratories
  • 11.7.1 Overview
  • 11.7.2 Recent Development
  • 11.7.3 Financial Insights